Results 141 to 150 of about 17,734 (168)

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials. [PDF]

Front Oncol
Oganesyan A, Gregory A, Gregory M, Badalian D, Chakmanyan A, Harutyunyan L, Khachatryan V, Aradhya A, Javaid A, Hakobyan Y, Fidler CJ, Porcu P.   +11 more
europepmc   +1 more source

Is it time to increase the liposomal doxorubicin dosage for frontline therapy in young adults and adults with classic Hodgkin lymphoma? Comment on: "Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?" [PDF]

Haematologica
Picardi M, Vincenzi A.
europepmc   +1 more source

Insight of immune checkpoint blockades in melanoma: mechanism and clinical translation. [PDF]

Mol Cancer
Zhang Q, Yuan C, Zhu L, Zheng S, Xu Y, Che X, Xiao S, Liu J, Liu H, Li H, Chen X.   +10 more
europepmc   +1 more source

An Unusual Case of Upper Digestive Bleeding-Metastatic Amelanotic Melanoma: Case Report and Literature Review. [PDF]

Life (Basel)
Dranga M, Cijevschi Prelipcean C, Nedelciuc O, Jucan AE, Sârbu GE, Carmen A, Popa IV, Nemțeanu R, Ciortescu I, Ianole V, Mihai C.   +10 more
europepmc   +1 more source

Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma. [PDF]

Int J Mol Sci
Choi W, Ham W, Park JH, Sim SH, Chun JW, Kang M, Kim C, Hong W, Koh EB, Kang JH, Woo SM, Kim SY.   +11 more
europepmc   +1 more source

Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.

Blood
Abramson JS, Straus DJ, Bartlett NL, Burke JM, Lynch RC, Domingo Domenech E, Hess B, Schuster SR, Linhares Y, Gandhi M, Shah HR, Jurczak W, Re A, Hahn U, Prince HM, Guo W, Davis G, Ho L, Fanale M, Yasenchak CA, Lee HJ.   +20 more
europepmc   +1 more source

Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma

Carbohydrate Polymers, 2023
The aim of this study was to investigate the anti-melanoma and anti-angiogenic effects of enoxaparin surface-coated dacarbazine-loaded chitosan nanoparticles (Enox-Dac-Chi NPs).
Azade Taheri, Mahmoud Etebari
exaly   +2 more sources

Mechanisms of hepatotoxicity caused by dacarbazine in rats

Journal of Cancer Research and Clinical Oncology, 1993
Possible risks of fatal dacarbazine hepatotoxicity have not been studied systematically. We therefore asked whether dacarbazine hepatotoxicity is influenced by the dose or mode of application, by dacarbazine light-decay products, by prior liver damage or
Usadel, Klaus Henning, Heine, Michael, Paschke, Ralf, Braun, Sabine   +3 more
exaly   +2 more sources